Prolactin as an autocrine/paracrine factor in breast tissue

Journal of Mammary Gland Biology and Neoplasia

Volumn 2, Issue 1, 1997, Pages 59-68

  Clevenger, Charles V ^a   Plank, Tracey L ^a  

^a UNIVERSITY OF PENNSYLVANIA   (United States)

Author keywords

Apoptosis; Breast cancer; Cell proliferation; Growth factor; Prolactin receptor

Indexed keywords

PROLACTIN; PROLACTIN RECEPTOR;

ANIMAL; BREAST; BREAST TUMOR; EXPERIMENTAL NEOPLASM; FEMALE; GROWTH, DEVELOPMENT AND AGING; HUMAN; PHYSIOLOGY; REVIEW; UDDER;

ANIMALS; BREAST; BREAST NEOPLASMS; FEMALE; HUMANS; MAMMARY GLANDS, ANIMAL; MAMMARY NEOPLASMS, ANIMAL; PROLACTIN; RECEPTORS, PROLACTIN;

EID: 0030621563     PISSN: 10833021     EISSN: None     Source Type: Journal    
DOI: 10.1023/A:1026325630359     Document Type: Article

References (73)

1. G. W. Beatson (1896). On the treatment of inoperable cases of carcinoma of the mamma: Suggestions for a new method of treatment with illustrative cases. Lancet 2:104-110.
2. S. A. W. Fuqua, G. C. Chamness, and W. L. McGuire (1993). Estrogen receptor mutations in breast cancer. J. Cell. Biochem. 51:135-139.
3. D. Tripathy and C. Benz (1994). Growth factors and their receptors. Hematology/Oncology Clinics 8:29-50.
4. C. J. Ormandy and R. L. Sutherland (1993). Mechanisms of prolactin receptor regulation in mammary gland. Mol. Cell. Endocrinol. 91:C1-C6.
5. P. A. Kelly, S. Ali, M. Rozakis, et al. (1993). The growth hormone/prolactin receptor family. Rec. Prog. Horm. Res. 48:123-164.
6. R. P. C. Shiu and B. M. Iwasiow (1985). Prolactin-inducible proteins in human breast cancer cells. J. Biol. Chem. 260:11307-11313.
7. W. A. Guyette, R. A. Matusik, and J. M. Rosen (1979). Prolactin-mediated transcriptional and post-transcriptional control of casein gene expression. Cell 17:1013-1023.
8. K. F. Lee, S. H. Atiee, and J. M. Rosen (1989). Differential regulation of rat β-casein-chloramphenical acetyltransferase fusion gene expression in transgenic mice. Mol. Cell Biol. 9:560-565.
9. J. M. Boutin, C. Jolicoeur, H. Okamura, J. Gagnon, M. Edery, M. Shirota, D. Banville, I. Dusanter-Fourt, J. Djiane, and P. A. Kelly (1988). Cloning and expression of the rat prolactin receptor, a member of the growth hormone/prolactin receptor gene family. Cell 53:69-77.
10. J. M. Boutin, M. Edery, M. Shirota, C. Jolicoeur, L. Lesueur, S. Ali, D. Gould, J. Djiane, and P. Kelly (1989). Identification of a cDNA encoding a long form of prolactin receptor in human hepatoma and breast cancer cells. Mol. Endocrinol. 3:1455-1461.
11. C. W. Welsch and H. Nagasawa (1977). Prolactin and murine mammary tumorigenesis: A review. Cancer Res. 37:951-963.
12. C. W. Welsch (1985). Host factors affecting the frowth of carcinogen-induced rat mammary carcinomas: A review and tribute to Charles Brenton Huggins. Cancer Res. 45:3415-3443.
13. O. Muhlbock and L. M. Boot (1959). Induction of mammary cancer in mice without the mammary tumor agent by isografts of hypophyses. Cancer Res. 19:402-412.
14. C. W. Welsch, T. W. Jenkins, and J. Meites (1970). Increased incidence of mammary tumors in the female rat grafted with multiple pituitaries. Cancer Res. 30:1024-1029.
15. J. W. Everett (1954). Luteotrophic function of autografts of the rat hypophysis. Endocrinology 54:685-690.
16. J.E. Bruhl and D. G. Montemurro (1971). Effect of hypothalamic lesions on the genesis of spontaneous mammary gland tumors in the mouse. Cancer Res. 31:854-863.
17. C. W. Welsch (1973). Prophylaxis of spontaneously developing mammary carcinoma in C3H/HeJ female mice by suppression of prolactin. Cancer Res. 33:2939-2946.
18. H.A. Bern and S. Nandi (1961). Recent studies of the hormonal influence in mouse mammary tumorgenesis. Prog. in Experimental Tumor Res. 2:90-144.
19. R. L. Noble and J. H. Cutts (1959). Mammary tumors of the rat: A Review. Cancer Res. 19:1125-1139.
20. L. M. Boot, O. Muhlbock, and G. Ropcke (1962). Prolactin and the induction of mammary tumors in mice. Gen. Comp. Endocrinol. 2:601-603.
21. N. Haran-Ghera (1961). The role of mammotrophin in mammary mumor induction in mice. Cancer Res. 21:790-795.
22. F. K. Lin, M. R. Banerjee, and L. R. Crump (1976). Cell cycle-related hormone carcinogen interaction during chemical carcinogen induction of nodule-like mammary lesions in organ culture. Cancer Res. 36:1607-1614.
23. C. W. Welsch (1976). Interaction of estrogen and prolactin in spontaneous mammary tumorgenesis of the mouse. J. Toxicol. Environ. Health 1:161-175.
24. H. J. Chen and J. Meites (1970). Effects of estrogen and progesterone on serum and pituitary prolactin levels in ovariectomized rats. Endocrinology 86:503-505.
25. D. P. Rose and B. T. Pruitt (1981). Plasma prolactin levels in patients with breast cancer. Cancer 48:2687-2691.
26. D. M. Ingram, E. M. Nottage, and A. N. Roberts (1990). Prolactin and breast cancer risk. Med. J. Australia 153:469-473.
27. D. Y. Wang, K. A. Stepniewska, D. S. Allen, I. S. Fentiman, R. D. Bulbrook, H. G. Kwa, B. L. De Stavola, and M. J. Reed (1995). Serum prolactin levels and their relationship to survival in women with operable breast cancer. J. Clin. Epidemiol. 48:959-968.
28. J. M. Bhatavdekar, D. D. Patel, G. V. Sherbet, D. D. Giri, N. H. Karelia, H. H. Vora, N. G. Shah, T. P. Suthar, S. P. Nadkarni, and D. B. Balar (1993). Prognostic significance of plasma prolactin in breast cancer: Comparison with the expression c-erbB2 oncoprotein. Eur. J. Surgical Oncol. 19:409-413.
29. W. Holkamp, G. A. Nagel, H.-E. Wander, H. F. Rauschecker, and D. VonHeyden (1984). Hyperprolactinemia is an indicator of progressive disease and poor prognosis in advanced breast cancer. Int. J. Cancer 34:323-328.
30. M. Dowsett, G. E. McGarrick, A. L. Harris, R. C. Coombes, I. E. Smith, and S. L. Jeffcoate (1983). Prognostic significance of serum prolactin levels in advanced breast cancer. Br. J. Cancer 47:763-769.
31. S. E. Hankinson, G. A. Colditz, D. J. Hunter, J. E. Manson, W. C. Willett, M. J. Stampfer, C. Longcope, and F. E. Speizer (1995). Reproductive factors and family history of breast cancer in relation to plasma estrogen and prolactin levels in postmenopausal women in the Nurses' Health Study (United States). Cancer Causes and Control 6:217-224.
32. D. Y. Wang, B. L. De Stavola, R. D. Bulbrook, D. S. Allen, H. G. Kwa, I. S. Fentiman, J. L. Hayward, and R. R. Millis (1992). Relationship of blood prolactin levels and the risk of subsequent breast cancer. Int. J. Epidemiol. 21:214-221.
33. P. F. Bruning, J. M. G. Bonfrer, A. A. M. Hart, M. de Jong-Bakker, H. G. Kwa, W. Nooyen, and A. A. Verstraten (1984). Parity and age influence hormonal risk factors of breast cancer. Progr. Cancer Res. Therapy 31:335-342.
34. E. Anderson, H. Morten, D. Y. Wang, P. Burns, J. Birch, and A. Howell (1989). Serum bioactive lactogenic hormone levels in women with familial breast cancer and their relatives. Eur. J. Cancer 25:1719-1725.
35. P. R. Maddox, D. L. Jones, and R. E. Mansel (1992). Prolactin and total lactogenic hormone measured by microbioassay and immunoassay in breast cancer. Br. J. Cancer 65:456-460.
36. P. A. Baghurst, J. A. Carman, J. A. Syrette, K. I. Baghurst, and J. M. Crocker (1992). Diet, prolactin, and breast cancer. Am. J. Clin. Nutr. 56:943-949.
37. V. C. Musey, D. C. Collins, P. I. Musey, D. Martino-Saltzman, and J. R. K. Preedy (1987). Long-term effect of a first pregnancy on the secretion of prolactin. NEJM 316:229-234.
38. S. E. Hankinson, W. C. Willett, J. E. Manson, D. J. Hunter, G. A. Colditz, M. J. Stampfer, C. Longcope, and F. E. Speizer (1995). Alcohol, height, and adiposity in relation to estrogen and prolactin levels in postmenopausal women. JNCI 87:1297-1302.
39. W. S. Oetting, P. T. Tuazon, J. A. Traugh, and A. M. Walker (1986). Phosphorylation of prolactin. J. Biol. Chem. 261:1649-1652.
40. J. P. Peyrat, P. H. Venin, J. Bonneterre, B. Hecquet, B. Vandewalle, P. Kelly, and J. Dijane (1984). Effect of bomocriptine treatment on prolactin and steroid receptor levels in human breast cancer. Eur. J. Cancer Clin. Oncol. 20:1363-1367.
41. J. C. Heuson, A. Coune, and M. Staquet (1972). Clinical trial of 2-Br-a-ergocryptine (CB154) in advanced breast cancer. Eur. J. Cancer 8:155-156.
42. J. Bonneterre, L. Mauriac, B. Weber, H. Roche, P. Fargeot, M. Tubiana-Hulin, M. Sevin, P. Chollet, and P. Cappelaere (1988). Tamoxifen plus bromocriptine versus tamoxifen plus placebo in advanced breast cancer: Results of a double blind multicenter clinical trial. Eur. J. Cancer 24:1851-1853.
43. E. Anderson, J. E. Ferguson, H. Morten, S. M. Shalet, E. L. Robinson, and A. Howell (1993). Serum immunoreactive and bioactive lactogenic homones in advanced breast cancer patients treated with bromocriptine and octreotide. Eur. J. Cancer 29A:209-217.
44. G. C. L. Lachelin, S. S. C. Yen, and J. F. N. Alksne (1977). Hormonal changes following hypophysectomy in humans. Obstet. Gynecol. 50:333-339.
45. B. J. Giss and A. M. Walker (1985). Mammotroph autoregulation: Intracellular fate of internalized prolactin. Mol. Cell. Endocrinol. 42:259-267.
46. C. V. Clevenger, D. H. Russell, P. M. Appasamy, and M. B. Prystowsky (1990). Regulation of IL2-driven T-lymphocyte proliferation by prolactin. Proc. Natl. Acad. Sci. U.S.A. 87:6460-6464.
47. B. Gellersen, R. Kempf, R. Telgmann, and G. E. DiMattia (1994). Nonpituitary human prolactin gene transcription is independent of pit-1 and differentially controlled in lymphocytes and in endometrial stoma. Mol. Endocrinol. 8:356-373.
48. C. V. Clevenger, A. L. Sillman, J. Hanley-Hyde, and M. B. Prystowsky (1992). Requirement for prolactin during cell cycle regulated gene expression in cloned T-lymphocytes. Endocrinology 130:3216-3222.
49. L. A. Ellis and M. F. Picciano (1995). Bioactive and immunoreactive prolactin variants in human milk. Endocrinology 136:271-2720.
50. J. M. Nolin and R. J. Witorsch (1978). Detection of endogenous immunoreactive prolactin in rat mammary epithelial cells during lactation. Endocrinology 99:949-958.
51. A. Kurtz, L. A. Bristol, B. E. Toth, E. Lazar-Wesley, L. Takacs, and B. Kacsoh (1993). Mammary epithelial cells of lactating rats express prolactin messenger ribonucleic acid. Biol. Reprod. 48:1095-1103.
52. R. W. Steinmetz, A. L. Grant, and P. V. Malven (1993). Transcription of prolactin gene in milk secretory cells of the rat mammary gland. J. Endocrinol. 136:271-276.
53. K. Fields, E. Kulig, and R. V. Lloyd (1993). Detection of prolactin messenger RNA in mammary and other normal and neoplastic tissues by polymerase chain reaction. Lab. Invest. 68:354-360.
54. C. V. Clevenger, W.-P. Chang, W. Ngo, T. L. M. Pasha, K. T. Montone, and J. E. Tomaszewski (1995). Expression of prolactin and prolactin receptor in human breast carcinoma: Evidence for an autocrine/paracrine loop. Am. J. Pathol. 146:1-11.
55. C. Reynolds, K. T. Montone, C. M. Powell, J. E. Tomaszewski, and C. V. Clevenger (1997). Distribution of prolactin and its receptor in human breast carcinoma (Submitted).
56. E. Ginsburg and B. K. Vonderhaar (1995). Prolactin synthesis and secretion by human breast cancer cells. Cancer Res. 55:2591-2595.
57. J. Mershon, W. Sall, N. Mitchner, and N. Ben-Jonathan (1995). Prolactin is a local growth factor in rat mammary tumors. Endocrinology 136:3619-3623.
58. S. De Placido, C. Gallo, F. Perrone, A. Marinelli, C. Pagliarula, C. Carlomagno, G. Petrella, M. D'Istria, G. Delrio, and A. R. Bianco (1990). Prolactin receptor does not correlate with oestrogen and progesterone receptors in primary breast cancer and lacks prognostic significance. Ten year results of the Naples adjuvant (GUN) study. Br. J. Cancer 62:643-646.
59. J. Bonneterre, J. P. Peyrat, R. Beuscart, and A. Demaille (1986). Correlation between prolactin receptors, estradiol, and progesterone receptors in human breast cancer. Eur. J. Cancer Clin. Oncol. 22:1331-1336.
60. 2) expresses a mutant form of prolactin receptor. J. Biol. Chem. 266:20110-20117.
61. M. Shirota, D. Banville, S. Ali, C. Jolicouer, J. M. Boutin, M. Edery, J. Djiane, and P. A. Kelly (1990). Expression of two forms of prolactin receptor in rat ovary and liver. Mol. Endocrinol. 4:1136-1143.
62. R. P. C. Shiu, L. C. Murphy, D. Tsuyuki, Y. Myal, M. Lee-Wing, and B. Iwasiow (1987). Biological actions of prolactin in human breast carcinoma. Rec. Prog. Horm. Res. 43:277-299.
63. M. E. Lippman, C. K. Osborne, R. Knazek, and N. Young (1977). In vitro model systems for the study of hormone-dependent human breast cancer. NEJM 296:154-159.
64. A. Manni, C. Wright, G. Davis, J. Glenn, R. Joehl, and P. Feil (1986). Promotion by prolactin of the growth of human breast neoplasms cultured in vitro in the soft agar clonogenic assay. Cancer Res. 46:1669-1672.
65. W. B. Malarkey, M. Kennedy, L. E. Allred, and G. Milo (1983). Physiological concentrations of prolactin can promote the growth of human breast tumor cells in culture. J. Clin. Endocrinol. Metab. 56:673-677.
66. R. Biswas and B. K. Vonderhaar (1987). Role of serum in the prolactin responsiveness of MCF-7 human breast cancer cells in long-term tissue culture. Cancer Res. 47:3509-3514.
67. G. Fuh and J. A. Well (1995). Prolactin receptor antagonists that inhibit the growth of breast cancer cell lines. J. Biol. Chem. 270:13133-13137.
68. M. T. Travers, M. C. Barber, E. Tonner, L. Quarrie, J. Wilde, and D. J. Flint (1996). The role of prolactin and growth hormone in the regulation of casein gene expression and mammary cell survival: Relationships to milk synthesis and secretion. Endocrinology 137:1530-1539.
69. D. Jackson, O. V. Vopert, N. Bouck, and D. I. H. Linzer (1994). Stimulation and inhibition of angiogenesis by placental proliferin and proliferin related protein. 266:1581-1584.
70. M. Berwaer, P. Monget, B. Peers, M. Mathy-Hartet, E. Bellefroid, J. R. E. Davies, A. Belayew, and J. A. Martial (1991). Multihormonal regulation of the human prolactin gene expression from 5000 bp of its upstream sequence. Mol. Cell. Endocrinol. 80:53-64.
71. M. Delhase, P. Vergani, A. Malur, E. L. Hooghe-Peters, and R. J. Hooghe (1993). The transcription factor Pit-1/GHF-1 is expressed in hemopoietic and lymphoid tissues. Eur. J. Immunol. 23:951-955.
72. P. A. Gonnella, P. Harmatz, and W. A. Walker (1989). Prolactin is transported across the epithelium of the jejunum and ileum of the suckling rat. J. Cell. Physiol. 140:138-149.
73. L. A. Ellis, A. M. Mastro, and M. F. Picciano (1996). Milk-borne prolactin and neonatal development. J. Mam. Gland Biol. Neoplasia 1:259-269.